Measles, Mumps and Rubella Vaccine (Bio-Manguinhos/Fiocruz)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Measles, Mumps and Rubella Vaccine (Bio-Manguinhos/Fiocruz), covering 2016-07-11 to 2016-07-11. Get the full timeline:
Most recent: Clinical Trial Update: Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months. [Phase 3]